August 2020

Earlier this summer, the United States Attorney’s Office for the District of Massachusetts filed a lawsuit against Regeneron…

Dr. Seth B. Whitelaw, Editor for the Policy & Medicine Compliance Update  (1) As Summer 2020 begins winding down, we are now…

In June 2020, the United States Court of Appeals for the Eighth Circuit affirmed the dismissal with prejudice of a qui tam suit…

On June 17, 2020, the Health Subcommittee of the United States House of Representatives’ Committee on Energy and Commerce held a…

We have previously written about the downward slope of enforcement letters from the United States Food and Drug Administration…

In a recently proposed rule, the FDA proposed Right to Try law requirements. The agency will require drug manufacturers to issue…

The United States Department of Justice recently announced that it does not plan to challenge proposed efforts by a handful of…

Recently, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would materially modify current…

The Federal Trade Commission (“FTC”) recently released its annual report for 2019. The FTC’s annual report details the FTC’s…

Earlier this year, the United States Food and Drug Administration (FDA) announced it would no longer pursue a proposed regulatory…